Patients with previously untreated advanced squamous non-small-cell lung cancer lived significantly longer without their disease worsening when treated with ivonescimab, a bispecific antibody ...

The phase 3 KEYNOTE-D46/EVOKE-03 study evaluated sacituzumab govitecan/pembrolizumab vs pembrolizumab in untreated PD-L1-high metastatic NSCLC.

There are many treatment options for lung cancer, but the right one for you will depend on many factors including the type of lung cancer you have. Non-small-cell lung cancer (NSCLC) is the most ...

BRAF-positive non-small cell lung cancer (NSCLC) treatments can use the BRAF biomarker to provide effective, targeted treatment for this subset of lung cancer. BRAF-positive NSCLC is an uncommon or ...

GlaxoSmithKline (GSK) has agreed to acquire Nuvalent for $10.6 billion, the companies said, in a deal designed to strengthen the buyer’s cancer pipeline with Nuvalent’s precision oncology ...

About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in ...

Experts have described the findings as a ‘promising step forward‘ for patients with advanced squamous non-small cell lung ...

It's natural to feel afraid after a lung cancer diagnosis. But there's also real reason for hope, as treatment for lung cancer has improved dramatically in the last decade. (DigitalVision/Getty Images ...

The two main categories for lung cancer are small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Large cell lung cancer (LCLC) is a type of NSCLC. While the conditions share some ...

The Lung Cancer Research Foundation (LCRF), in collaboration with AstraZeneca, today announced that two research awards ...

Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...

Gary Knauer, 77, was diagnosed with stage 3 non-small cell lung cancer after a persistent cough led to testing. Seeking top ...